Asterias Biotherapeutics, Inc.. (AST) NYSE American
$0.95 - (-)
Market Cap: $52.32M
As of 03/07/19 04:00 PM EST. Market closed.
Asterias Biotherapeutics, Inc.. (AST)
NYSE American
$0.95
- (-)
Market Cap: $52.32M
As of 03/07/19 04:00 PM EST. Market closed.
Add to Portfolio
Operates as a biotechnology ... read more
COMPANY PROFILE
Sector
Health Technology
Industry
Biotechnology
CEO
Michael H. Mulroy
Full Time Employees
31
CEO Compensation (Base)
$241,947
CEO Compensation (Total)
$2.39M
Sector
Health Technology
Industry
Biotechnology
CEO
Michael H. Mulroy
Full Time Employees
31
CEO Compensation (Base)
$241,947
CEO Compensation (Total)
$2.39M
Address
6300 Dumbarton Circle, CA, Fremont, 94555.
PRICE CHART FOR ASTERIAS BIOTHERAPEUTICS, INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
-
Days Range
- - -
52 week range
$0.51 - $2.05
Volume
0
Avg. Volume (30 days)
149,158
Market Cap
$52.32M
Dividend Yield
-
P/E
-
Shares Outstanding
55,659,000
Open
-
Previous Close
-
Days Range
- - -
52 week range
$0.51 - $2.05
Volume
0
Avg. Volume (30 days)
149,158
Market Cap
$52.32M
Dividend Yield
-
P/E
-
Shares Outstanding
55,659,000
FINANCIAL STATEMENTS FOR ASTERIAS BIOTHERAPEUTICS, INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR ASTERIAS BIOTHERAPEUTICS, INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Wirth Edward | Chief Medical Officer | Mar 01, 2019 | Option Exercise | $0.95 | 48,826 | 46,385 | 267,194 | Mar 05, 2019, 04:32 PM |
| Mulroy Michael H. | President and CEO | Mar 01, 2019 | Option Exercise | $0.95 | 76,588 | 72,759 | 273,622 | Mar 05, 2019, 04:31 PM |
| Chavez Ryan Daniel | CFO and General Counsel | Mar 01, 2019 | Option Exercise | $0.95 | 44,471 | 42,247 | 255,509 | Mar 05, 2019, 04:30 PM |
| Chavez Ryan Daniel | CFO and General Counsel | Jan 02, 2019 | Option Exercise | $0.68 | 20,440 | 13,899 | 154,717 | Jan 04, 2019, 05:05 PM |
| Wirth Edward | Chief Medical Officer | Jan 02, 2019 | Option Exercise | $0.68 | 20,440 | 13,899 | 159,568 | Jan 04, 2019, 05:02 PM |
| Mulroy Michael H. | President and CEO | Aug 27, 2018 | Buy | $1.59 | 3,141 | 5,000 | 97,604 | Aug 29, 2018, 08:02 AM |
| Mulroy Michael H. | President and CEO | Jul 25, 2018 | Buy | $1.69 | 2,950 | 5,000 | 94,463 | Jul 27, 2018, 04:00 PM |
| Mulroy Michael H. | President and CEO | Jun 25, 2018 | Buy | $1.63 | 3,067 | 4,999 | 91,513 | Jun 27, 2018, 07:03 AM |
| Mulroy Michael H. | President and CEO | May 25, 2018 | Buy | $1.59 | 3,153 | 5,000 | 88,446 | May 31, 2018, 05:00 PM |
| Mulroy Michael H. | President and CEO | Apr 25, 2018 | Buy | $1.33 | 3,752 | 4,990 | 85,293 | Apr 27, 2018, 04:33 PM |
| Wirth Edward | Chief Medical Officer | Mar 30, 2018 | Option Exercise | $1.45 | 6,483 | 9,400 | 180,008 | Mar 30, 2018, 04:58 PM |
| Chavez Ryan Daniel | CFO and General Counsel | Mar 30, 2018 | Option Exercise | $1.45 | 6,483 | 9,400 | 175,157 | Mar 30, 2018, 04:54 PM |
| Mulroy Michael H. | President and CEO | Mar 26, 2018 | Buy | $1.76 | 2,839 | 4,997 | 81,541 | Mar 28, 2018, 05:00 PM |
| Mulroy Michael H. | President and CEO | Mar 15, 2018 | Option Exercise | $1.95 | 28,358 | 55,298 | 78,702 | Mar 19, 2018, 07:03 PM |
| Wirth Edward | Chief Medical Officer | Mar 15, 2018 | Option Exercise | $1.95 | 22,686 | 44,238 | 186,491 | Mar 19, 2018, 06:58 PM |
| Chavez Ryan Daniel | CFO and General Counsel | Mar 15, 2018 | Option Exercise | $1.95 | 21,633 | 42,184 | 181,640 | Mar 19, 2018, 06:52 PM |
| Mulroy Michael H. | President and CEO | Feb 26, 2018 | Buy | $2.22 | 2,255 | 5,000 | 12,188 | Feb 28, 2018, 04:21 PM |
| Mulroy Michael H. | President and CEO | Jan 25, 2018 | Buy | $2.34 | 2,134 | 5,000 | 9,933 | Jan 26, 2018, 04:01 PM |
| Mulroy Michael H. | President and CEO | Dec 26, 2017 | Buy | $2.22 | 2,247 | 4,988 | 7,799 | Dec 28, 2017, 07:41 PM |
| Mulroy Michael H. | President and CEO | Nov 27, 2017 | Buy | $2.41 | 2,076 | 5,003 | 5,552 | Nov 29, 2017, 04:01 PM |
| Mulroy Michael H. | President and CEO | Oct 25, 2017 | Buy | $2.55 | 1,939 | 4,944 | 3,476 | Oct 27, 2017, 04:00 PM |
| Mulroy Michael H. | President and CEO | Sep 25, 2017 | Buy | $3.25 | 1,537 | 4,997 | 1,537 | Sep 27, 2017, 02:04 PM |
| Wirth Edward | Chief Medical Officer | Jun 05, 2017 | Option Exercise | $3.20 | 6,745 | 21,584 | 85,177 | Jun 07, 2017, 04:30 PM |
| Spink Katharine E. | EVP & COO | Jun 05, 2017 | Option Exercise | $3.20 | 7,260 | 23,232 | 10,949 | Jun 07, 2017, 04:30 PM |
| LEBKOWSKI JANE | Chief Scientific Officer | Jun 05, 2017 | Option Exercise | $3.20 | 7,015 | 22,448 | 102,991 | Jun 07, 2017, 04:30 PM |
| Wirth Edward | Chief Medical Officer | Jan 09, 2017 | Sale | $4.60 | 3,415 | 15,719 | 0 | Jan 11, 2017, 04:30 PM |
| Spink Katharine E. | Chief Operating Officer | Jan 09, 2017 | Sale | $4.60 | 4,781 | 22,007 | 0 | Jan 11, 2017, 04:30 PM |
| Spink Katharine E. | Chief Operating Officer | Dec 27, 2016 | Option Exercise | $2.34 | 2,500 | 5,850 | 2,500 | Jan 06, 2017, 05:15 PM |
| Spink Katharine E. | Chief Operating Officer | Dec 27, 2016 | Sale | $5.00 | 2,500 | 12,500 | 0 | Jan 06, 2017, 05:15 PM |
| Wirth Edward | Chief Medical Officer | Dec 27, 2016 | Option Exercise | $2.34 | 2,500 | 5,850 | 2,500 | Jan 06, 2017, 05:13 PM |
| Wirth Edward | Chief Medical Officer | Dec 27, 2016 | Sale | $5.00 | 2,500 | 12,500 | 0 | Jan 06, 2017, 05:13 PM |
| Spink Katharine E. | Chief Operating Officer | Nov 23, 2016 | Option Exercise | $2.34 | 2,500 | 5,850 | 2,500 | Nov 28, 2016, 04:30 PM |
| Spink Katharine E. | Chief Operating Officer | Nov 23, 2016 | Sale | $5.41 | 2,500 | 13,525 | 0 | Nov 28, 2016, 04:30 PM |
| Wirth Edward | Chief Medical Officer | Nov 17, 2016 | Option Exercise | $2.34 | 2,500 | 5,850 | 2,500 | Nov 21, 2016, 04:48 PM |
| Wirth Edward | Chief Medical Officer | Nov 17, 2016 | Sale | $5.00 | 2,500 | 12,500 | 0 | Nov 21, 2016, 04:48 PM |
| Spink Katharine E. | Chief Operating Officer | Nov 17, 2016 | Option Exercise | $2.34 | 2,500 | 5,850 | 2,500 | Nov 21, 2016, 04:43 PM |
| Spink Katharine E. | Chief Operating Officer | Nov 17, 2016 | Sale | $5.00 | 2,500 | 12,500 | 0 | Nov 21, 2016, 04:43 PM |
| Spink Katharine E. | Chief Operating Officer | Oct 06, 2016 | Sale | $4.11 | 4,781 | 19,635 | 0 | Oct 11, 2016, 07:02 AM |
| Wirth Edward | Chief Medical Officer | Oct 06, 2016 | Sale | $4.12 | 3,415 | 14,084 | 0 | Oct 11, 2016, 07:01 AM |
| Spink Katharine E. | Chief Operating Officer | Sep 09, 2016 | Sale | $3.54 | 9,608 | 33,989 | 0 | Sep 12, 2016, 05:00 PM |
| Spink Katharine E. | Chief Operating Officer | Sep 08, 2016 | Sale | $3.50 | 9,728 | 34,048 | 9,608 | Sep 12, 2016, 05:00 PM |
| Wirth Edward | Chief Medical Officer | Sep 09, 2016 | Sale | $3.58 | 3,179 | 11,384 | 0 | Sep 12, 2016, 05:00 PM |
| Wirth Edward | Chief Medical Officer | Sep 08, 2016 | Sale | $3.50 | 11,581 | 40,534 | 3,179 | Sep 12, 2016, 05:00 PM |
| LeBuhn Richard T. | Director | Jun 29, 2016 | Buy | $2.38 | 5,000 | 11,900 | 25,000 | Jul 01, 2016, 04:11 PM |
| Cartt Stephen LaHue | President and CEO | Jun 30, 2016 | Buy | $2.40 | 10,000 | 23,977 | 260,000 | Jul 01, 2016, 06:02 AM |
| Cartt Stephen LaHue | President and CEO | Jun 10, 2016 | Buy | $2.93 | 50,000 | 146,530 | 250,000 | Jun 13, 2016, 04:15 PM |
| KINGSLEY ALFRED D | Director | Jun 09, 2016 | Buy | $2.93 | 4,000 | 11,720 | 9,000 | Jun 10, 2016, 04:15 PM |
| BAILEY DON M | Director | May 13, 2016 | Buy | $3.39 | 88,235 | 299,117 | 88,235 | May 17, 2016, 10:58 AM |
| LeBuhn Richard T. | Director | May 13, 2016 | Buy | $3.39 | 15,000 | 50,850 | 20,000 | May 17, 2016, 10:54 AM |
| RICCIARDI NATALE S | Director | May 13, 2016 | Buy | $3.39 | 14,706 | 49,853 | 19,706 | May 17, 2016, 10:50 AM |
| LEBKOWSKI JANE | President of R&D | Sep 15, 2015 | Sale | $6.00 | 4,912 | 29,472 | 476 | Sep 16, 2015, 05:56 PM |
| Wirth Edward | Chief Medical Officer | Sep 15, 2015 | Sale | $6.00 | 2,880 | 17,280 | 0 | Sep 16, 2015, 05:52 PM |
| Spink Katharine E. | VP and Chief Operating Officer | Sep 15, 2015 | Sale | $6.00 | 3,760 | 22,560 | 0 | Sep 16, 2015, 05:49 PM |
| Spink Katharine E. | VP and Chief Operating Officer | Jun 30, 2015 | Option Exercise | $4.60 | 3,291 | 15,139 | 3,760 | Jul 02, 2015, 04:30 PM |
| Wirth Edward | Chief Medical Officer | Jun 30, 2015 | Option Exercise | $4.60 | 1,668 | 7,673 | 2,880 | Jul 02, 2015, 04:30 PM |
| LEBKOWSKI JANE | President of R&D | Jun 30, 2015 | Option Exercise | $4.60 | 2,844 | 13,082 | 5,388 | Jul 02, 2015, 04:30 PM |
| LeBuhn Richard T. | Director | Jun 25, 2015 | Buy | $4.41 | 5,000 | 22,062 | 5,000 | Jun 26, 2015, 08:30 AM |
| KINGSLEY ALFRED D | Director | Jun 25, 2015 | Buy | $4.32 | 5,000 | 21,577 | 5,000 | Jun 26, 2015, 08:30 AM |
| Arno Andrew | Director | Jun 25, 2015 | Buy | $4.32 | 5,000 | 21,600 | 5,000 | Jun 26, 2015, 08:30 AM |
| RICCIARDI NATALE S | Director | Jun 25, 2015 | Buy | $4.39 | 5,000 | 21,975 | 5,000 | Jun 26, 2015, 08:30 AM |
| BROADWOOD PARTNERS LP | See Remarks Section | May 21, 2015 | Option Exercise | $2.34 | 1,000,000 | 2,340,000 | 1,641,025 | May 26, 2015, 05:47 PM |
| LICHTINGER PEDRO | Chief Executive Officer | Feb 09, 2015 | Buy | $3.90 | 128,205 | 500,000 | 528,205 | Feb 11, 2015, 07:35 PM |
| BROADWOOD PARTNERS LP | See Remarks Section | Feb 10, 2015 | Option Exercise | $3.90 | 641,025 | 2,499,998 | 641,025 | Feb 11, 2015, 05:52 PM |
| Scarsdale Equities LLC | Former 10% Owner | Sep 29, 2014 | Buy | $5.73 | 10,000 | 57,260 | 836,000 | Oct 06, 2014, 04:04 PM |
| Scarsdale Equities LLC | Former 10% Owner | Oct 01, 2014 | Buy | $5.97 | 50,000 | 298,355 | 886,000 | Oct 06, 2014, 04:04 PM |
| Scarsdale Equities LLC | 10% Owner | Sep 24, 2014 | Buy | $5.35 | 10,000 | 53,536 | 826,000 | Sep 25, 2014, 03:37 PM |
| Scarsdale Equities LLC | 10% Owner | Sep 23, 2014 | Buy | $4.58 | 15,000 | 68,660 | 816,000 | Sep 25, 2014, 03:37 PM |
| Scarsdale Equities LLC | 10% Owner | Sep 05, 2014 | Buy | $5.48 | 30,000 | 164,346 | 806,000 | Sep 08, 2014, 01:42 PM |
| Scarsdale Equities LLC | 10% Owner | Sep 04, 2014 | Buy | $4.00 | 70,000 | 279,797 | 776,000 | Sep 08, 2014, 01:42 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Wirth Edward | Chief Medical Officer | 03/01/2019 | 46,385 |
| Mulroy Michael H. | President and CEO | 03/01/2019 | 72,759 |
| Chavez Ryan Daniel | CFO and General Counsel | 03/01/2019 | 42,247 |
| Chavez Ryan Daniel | CFO and General Counsel | 01/02/2019 | 13,899 |
| Wirth Edward | Chief Medical Officer | 01/02/2019 | 13,899 |
| Mulroy Michael H. | President and CEO | 08/27/2018 | 5,000 |
| Mulroy Michael H. | President and CEO | 07/25/2018 | 5,000 |
| Mulroy Michael H. | President and CEO | 06/25/2018 | 4,999 |
| Mulroy Michael H. | President and CEO | 05/25/2018 | 5,000 |
| Mulroy Michael H. | President and CEO | 04/25/2018 | 4,990 |
| Wirth Edward | Chief Medical Officer | 03/30/2018 | 9,400 |
| Chavez Ryan Daniel | CFO and General Counsel | 03/30/2018 | 9,400 |
| Mulroy Michael H. | President and CEO | 03/26/2018 | 4,997 |
| Mulroy Michael H. | President and CEO | 03/15/2018 | 55,298 |
| Wirth Edward | Chief Medical Officer | 03/15/2018 | 44,238 |
| Chavez Ryan Daniel | CFO and General Counsel | 03/15/2018 | 42,184 |
| Mulroy Michael H. | President and CEO | 02/26/2018 | 5,000 |
| Mulroy Michael H. | President and CEO | 01/25/2018 | 5,000 |
| Mulroy Michael H. | President and CEO | 12/26/2017 | 4,988 |
| Mulroy Michael H. | President and CEO | 11/27/2017 | 5,003 |
| Mulroy Michael H. | President and CEO | 10/25/2017 | 4,944 |
| Mulroy Michael H. | President and CEO | 09/25/2017 | 4,997 |
| Wirth Edward | Chief Medical Officer | 06/05/2017 | 21,584 |
| Spink Katharine E. | EVP & COO | 06/05/2017 | 23,232 |
| LEBKOWSKI JANE | Chief Scientific Officer | 06/05/2017 | 22,448 |
| Wirth Edward | Chief Medical Officer | 01/09/2017 | 15,719 |
| Spink Katharine E. | Chief Operating Officer | 01/09/2017 | 22,007 |
| Spink Katharine E. | Chief Operating Officer | 12/27/2016 | 5,850 |
| Spink Katharine E. | Chief Operating Officer | 12/27/2016 | 12,500 |
| Wirth Edward | Chief Medical Officer | 12/27/2016 | 5,850 |
| Wirth Edward | Chief Medical Officer | 12/27/2016 | 12,500 |
| Spink Katharine E. | Chief Operating Officer | 11/23/2016 | 5,850 |
| Spink Katharine E. | Chief Operating Officer | 11/23/2016 | 13,525 |
| Wirth Edward | Chief Medical Officer | 11/17/2016 | 5,850 |
| Wirth Edward | Chief Medical Officer | 11/17/2016 | 12,500 |
| Spink Katharine E. | Chief Operating Officer | 11/17/2016 | 5,850 |
| Spink Katharine E. | Chief Operating Officer | 11/17/2016 | 12,500 |
| Spink Katharine E. | Chief Operating Officer | 10/06/2016 | 19,635 |
| Wirth Edward | Chief Medical Officer | 10/06/2016 | 14,084 |
| Spink Katharine E. | Chief Operating Officer | 09/09/2016 | 33,989 |
| Spink Katharine E. | Chief Operating Officer | 09/08/2016 | 34,048 |
| Wirth Edward | Chief Medical Officer | 09/09/2016 | 11,384 |
| Wirth Edward | Chief Medical Officer | 09/08/2016 | 40,534 |
| LeBuhn Richard T. | Director | 06/29/2016 | 11,900 |
| Cartt Stephen LaHue | President and CEO | 06/30/2016 | 23,977 |
| Cartt Stephen LaHue | President and CEO | 06/10/2016 | 146,530 |
| KINGSLEY ALFRED D | Director | 06/09/2016 | 11,720 |
| BAILEY DON M | Director | 05/13/2016 | 299,117 |
| LeBuhn Richard T. | Director | 05/13/2016 | 50,850 |
| RICCIARDI NATALE S | Director | 05/13/2016 | 49,853 |
| LEBKOWSKI JANE | President of R&D | 09/15/2015 | 29,472 |
| Wirth Edward | Chief Medical Officer | 09/15/2015 | 17,280 |
| Spink Katharine E. | VP and Chief Operating Officer | 09/15/2015 | 22,560 |
| Spink Katharine E. | VP and Chief Operating Officer | 06/30/2015 | 15,139 |
| Wirth Edward | Chief Medical Officer | 06/30/2015 | 7,673 |
| LEBKOWSKI JANE | President of R&D | 06/30/2015 | 13,082 |
| LeBuhn Richard T. | Director | 06/25/2015 | 22,062 |
| KINGSLEY ALFRED D | Director | 06/25/2015 | 21,577 |
| Arno Andrew | Director | 06/25/2015 | 21,600 |
| RICCIARDI NATALE S | Director | 06/25/2015 | 21,975 |
| BROADWOOD PARTNERS LP | See Remarks Section | 05/21/2015 | 2,340,000 |
| LICHTINGER PEDRO | Chief Executive Officer | 02/09/2015 | 500,000 |
| BROADWOOD PARTNERS LP | See Remarks Section | 02/10/2015 | 2,499,998 |
| Scarsdale Equities LLC | Former 10% Owner | 09/29/2014 | 57,260 |
| Scarsdale Equities LLC | Former 10% Owner | 10/01/2014 | 298,355 |
| Scarsdale Equities LLC | 10% Owner | 09/24/2014 | 53,536 |
| Scarsdale Equities LLC | 10% Owner | 09/23/2014 | 68,660 |
| Scarsdale Equities LLC | 10% Owner | 09/05/2014 | 164,346 |
| Scarsdale Equities LLC | 10% Owner | 09/04/2014 | 279,797 |
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR ASTERIAS BIOTHERAPEUTICS, INC.
LOADING...